As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory building at the Leuven facility. Highlights include an expanded onsite PhD Team, new molecular suite, flow cytometry services grow, biorepository updates, and logistics/kit building expansion
Read More
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Read More
Experts from Medpace’s central laboratory evaluated the effect of hemolysis, icterus and lipemia on chemistry assays and assessed the association between the amount of interfering substances and ordinal values reported by the automated chemistry analyzer as H-, I- and L-indices. They presented their findings at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago.
Read More
Medpace offers global flow cytometry capabilities, with flow cytometry departments located at our US, Belgium and Singapore central laboratories.
Read More
With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.
Read More
As part of our mission to deliver superb customer service and site support, we have recently expanded our kit building capabilities in the US and are currently expanding in the rest of the world.
Read More
In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means for our Sponsors.
Read More
With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and benefits of treatment. Known for partnering with sponsors at a very high-level of scientific engagement, the expansion of our molecular suite (1,975 square feet) further enhances our ability to support sponsors with advanced testing to detect pathogenic events at the genome level.
Read More
Data from central laboratories have been key for assessing safety, tolerability, and efficacy of new drugs in clinical trials. With the increasing complexity and global scale of many clinical trials, it is important to maintain harmonization. Learn how we harmonize our data across our regional laboratories.
Read More
As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical trial.
Read More